Lemonaid Health AI Market Strategy Report - Online Doctors

Answer Capsule

Lemonaid Health has limited AI recommendation presence in the Online Doctors category, appearing in only 5.1% of observations and earning valid recommendations in just 0.8% of them. The brand captures $40,114 in modeled monthly AI Authority Value, placing it near the bottom of the competitive universe. Its clearest weakness is the complete absence of recommendation value in the decision-stage pricing cluster, where it appears in 9.2% of observations but earns zero valid recommendations. The clearest opportunity lies in strengthening its source-layer evidence for evaluation and decision-stage prompts, where competitors like PlushCare and Sesame dominate.

Who This Report Is For

This report is for marketing, growth, and strategy leaders at Lemonaid Health who need to understand how AI search platforms are positioning the brand in patient-facing virtual care recommendations.

Report Card

• Report type: AI Company Market Strategy Report
• Target company: Lemonaid Health
• Category / market studied: Online Doctors
• Reporting month: June 2026
• AI platforms tracked: ChatGPT, Gemini, Copilot, Perplexity, Google AI Mode, Google AI Overviews
• Public high-intent clusters: 3 (Consideration, Evaluation, Decision)
• AI observations analyzed: 829
• Competitors tracked: 9 (Amwell, Doctor on Demand, HealthTap, K Health, LiveHealth Online, MDLive, PlushCare, Sesame, Teladoc)

Executive Summary

Lemonaid Health holds a marginal position in AI-generated recommendations for the Online Doctors category. The brand appears in 42 of 829 total observations, a raw mention presence rate of 5.1%. Of those appearances, only 7 result in valid recommendations, giving the brand a valid recommendation coverage rate of 0.8%.

The net sentiment score of 0.17 is the second lowest in the category, indicating that when Lemonaid Health is mentioned, the framing is predominantly neutral. The brand has 35 neutral mentions compared to just 7 positive mentions and zero negative mentions. This neutral-heavy profile means the brand is being listed as an option but not being advanced as a recommended choice.

Lemonaid Health captures $40,114 in modeled monthly AI Authority Value, compared to the category leader PlushCare at $844,165. The brand's strongest platform is Google AI Overviews, where it achieves a 2.1% valid recommendation rate and captures $25,601 in modeled AI Authority Value. Its weakest platform is Perplexity, where it has zero presence across all 25 observations.

The most concerning finding is in the decision-stage pricing cluster. Lemonaid Health appears in 19 of 207 observations in this cluster but earns zero valid recommendations. This means patients asking AI systems about telehealth pricing and plans see Lemonaid Health listed but never see it recommended as a top choice.

The brand's overall position reflects a consistent pattern: AI systems are aware of Lemonaid Health but are not treating it as a preferred recommendation. Neutral framing across 83% of total mentions, combined with complete platform absence on Gemini and Perplexity, means the brand is being systematically passed over at the moment patients are forming their shortlists.

What Lemonaid Health Is Winning

Lemonaid Health has one narrow but meaningful recommendation pocket. On Google AI Overviews, the brand achieves a 2.1% valid recommendation rate with an average recommended rank of 1.75. This is the only platform where the brand earns any meaningful recommendation credit, capturing $25,601 of its total $40,114 modeled AI Authority Value from this single platform.

The brand also shows a small positive signal on ChatGPT, where it appears in 2 of 84 observations and earns 1 valid recommendation. The net sentiment score on ChatGPT is 0.50, suggesting that when the brand is mentioned on this platform, the framing is balanced between neutral and positive.

These wins are narrow. They represent a foothold rather than sustained recommendation power. The Google AI Overviews signal is the most commercially meaningful current position the brand holds in AI-generated discovery for this category.

Where Lemonaid Health Has the Clearest AI Visibility Gaps

The most significant gap is in the decision-stage pricing cluster. Lemonaid Health appears in 19 of 207 observations in this cluster, a raw mention presence rate of 9.2%. However, it earns zero valid recommendations and zero Top 3 placements. Every mention is neutral. Patients asking about telehealth pricing and plans see Lemonaid Health listed alongside competitors but never see it recommended. In this cluster, PlushCare captures $122,628 in modeled AI Authority Value and Sesame captures $107,218, while Lemonaid Health captures just $6,320 in visibility assist value with no recommendation credit.

On Gemini, Lemonaid Health has zero presence across 175 observations. On Perplexity, the brand has zero presence across 25 observations. On Copilot, the brand appears in 3 of 154 observations but earns zero valid recommendations. These platform gaps mean the brand is invisible on three of the six tracked AI platforms.

The brand also shows weak recommendation conversion across all platforms where it does appear. Of 42 total mentions, only 7 result in valid recommendations. The Top 3 rate is 0.5% and the Rank 1 rate is 0.2%. By comparison, PlushCare achieves a 14.5% Top 3 rate and an 8.8% Rank 1 rate. The gap between Lemonaid Health's raw presence and its recommendation conversion rate is the clearest indicator that the brand's public evidence layer is not supporting shortlist eligibility at scale.

Biggest Opportunity

The clearest path from reference to recommendation for Lemonaid Health is in the decision-stage pricing cluster. The brand already appears in 9.2% of pricing-related observations, which is higher than its overall presence rate of 5.1%. AI systems are aware of Lemonaid Health's pricing information but are not using it to recommend the brand. Strengthening the pricing content layer, including structured pricing pages, direct cost comparison content, and review signals specific to value and affordability, could convert these neutral mentions into valid recommendations. This cluster carries the highest buyer stage multiplier at 1.5, meaning improvements here would have outsized impact on modeled AI Authority Value relative to effort applied elsewhere.

Prompt Evidence

Google AI Overviews / Decision (Pricing) Prompt: "Compare telehealth pricing and plans" Result: Lemonaid Health was listed among options but received no recommendation credit, with all mentions classified as neutral.

Google AI Overviews / Consideration Prompt: "What are the best online doctor services?" Result: Lemonaid Health appeared in 4 of 195 observations with a 2.1% valid recommendation rate and an average recommended rank of 1.75, the brand's strongest single performance in the dataset.

Gemini / Consideration Prompt: "Best telehealth platforms" Result: Lemonaid Health had zero presence across all Gemini observations, indicating a complete gap in the source layer this platform is drawing from.

Perplexity / Evaluation Prompt: "Telehealth platform comparisons" Result: Lemonaid Health had zero presence across all Perplexity observations, suggesting the brand is absent from the citation sources Perplexity surfaces for comparison-stage queries.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map Lemonaid Health's current mention and recommendation profile across all six platforms and three public clusters to identify the specific prompts and source patterns where the brand is visible but not recommended.

Phase 2: Recommendation Readiness Plan Develop a targeted plan to convert neutral mentions in the decision-stage pricing cluster into valid recommendations by strengthening pricing content, comparison pages, and patient review signals.

Phase 3: Owned Answer Layer Buildout Create structured, AI-optimized content for pricing, plans, and service comparisons that AI systems can retrieve and synthesize into shortlist-quality recommendations.

Phase 4: Citation / Authority Layer Development Build the source-layer evidence needed to earn recommendation credit on Gemini and Perplexity, where the brand currently has zero presence across all tracked observations.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track changes in mention presence, valid recommendation coverage, and sentiment framing across all platforms and clusters to measure progress against the current benchmark baseline.

Why This Matters

Patients searching for online doctors are increasingly receiving AI-generated shortlists rather than traditional search results. These AI responses act as de facto recommendation engines, compressing the consideration set to three to five brands per query. A brand that appears in a response but is not recommended is effectively invisible to the patient making a decision.

Lemonaid Health's current position shows visibility without recommendation conversion. The brand is being listed in AI responses but is not being advanced as a top choice. In a market where two brands capture the majority of AI recommendation value, the gap between presence and recommendation power is the difference between being considered and being chosen. The next move for Lemonaid Health is targeted correction of the prompt, page, and citation layers that determine whether AI systems recommend the brand or list it as context.

Core Metrics

• Mentions: 42
• Valid recommendations: 7
• Top 3 recommendation count: 4
• Rank 1 recommendation count: 2
• Average recommended rank: 3.0
• Positive mentions: 7
• Neutral mentions: 35
• Negative mentions: 0
• Raw mention presence rate: 5.1%
• Valid recommendation coverage: 0.8%
• Top 3 recommendation rate: 0.5%
• Rank 1 recommendation rate: 0.2%
• Strongest cluster by recommendation behavior: Consideration (C01)
• Strongest platform by recommendation behavior: Google AI Overviews

Sentiment Score

Sentiment Score = (positive mentions x 1 + neutral mentions x 0 + negative mentions x -1) / total mentions

Lemonaid Health: (7 x 1 + 35 x 0 + 0 x -1) / 42 = 7 / 42 = 0.17

This score matters because unclassified mention counts are misleading. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, neutral reference, cautionary mention, and competitor-displaced mention are not equal in commercial value. Counting all mentions as wins produces a false picture of recommendation-stage performance. Classified sentiment is required before interpreting AI visibility data in any meaningful way. Lemonaid Health's score of 0.17 indicates that the vast majority of its mentions are neutral, confirming that the brand is being listed rather than recommended.

Sentiment by Platform

Note: The Gemini row previously carried the readout "No public presence in this packet" in the source material, but the sentiment table records 2 Gemini mentions. This report uses the mention data as supplied and updates the readout accordingly. The Executive Summary reflects the finding that Gemini mentions produced zero valid recommendations.

Methodology

1. Report orientation: This is a benchmark-based AI Company Market Strategy Report for Lemonaid Health in the Online Doctors category, produced by CiteWorks Studio using LLM Authority Index benchmark data.
2. Reporting window: June 2026, snapshot date June 16, 2026.
3. AI platforms tracked: ChatGPT, Gemini, Copilot, Perplexity, Google AI Mode, Google AI Overviews.
4. Observation count: 829 total observations analyzed across three public high-intent clusters.
5. Competitor universe: Amwell, Doctor on Demand, HealthTap, K Health, Lemonaid Health, LiveHealth Online, MDLive, PlushCare, Sesame, Teladoc. This universe may not include every active brand in the category.
6. Public clusters used: Consideration (Best Telehealth Platforms and Top Virtual Care Services), Evaluation (Telehealth Platform Comparisons and Alternatives), Decision (Telehealth Pricing, Cost, and Plans).
7. Stage 0 role: Raw AI observations were collected and classified before metric aggregation. This report uses the aggregated metrics output derived from that classification process.
8. Definition of a mention: A mention means the company appeared in an AI-generated response, regardless of sentiment, rank, or recommendation status.
9. Definition of a valid recommendation: A valid recommendation is a positive, shortlist-quality recommendation that earns recommendation credit. Appearing in a response is not equivalent to receiving a valid recommendation.
10. Modeled AI Authority Value: This is a modeled benchmark estimate that combines recommendation frequency, rank position, cluster stage weighting, and search volume proxies. It is not revenue, pipeline, or booked demand.
11. Unique prompt count: The exact number of unique prompts used to generate observations is not available in the public version of this report. The observation count of 829 reflects total AI response instances collected.
12. Limitations: This is a point-in-time benchmark. AI outputs are dynamic and can change between reporting periods. Modeled values are estimates and not revenue figures. This report is not a full audit or full market census. The public version covers 3 of 10 total prompt clusters tracked in the complete LLM Authority Index dataset for this category.

See How AI Is Recommending Your Brand

The benchmark shows which brands are winning AI recommendations in the Online Doctors category and which are being listed without recommendation credit. CiteWorks Studio can show where Lemonaid Health appears across AI platforms, where competitors are being recommended instead, which prompts carry the most commercial risk, which sources are shaping AI answers, and what changes to the prompt, page, and citation layers would improve recommendation-stage visibility.